This study looks at how the growth of blood cells, called clonal hematopoiesis (t-CH), affects heart health after treatment for Hodgkin Lymphoma. Hodgkin Lymphoma is a type of cancer that affects the lymph system, part of the body's immune system. The study is important because some cancer treatments can cause heart problems later in life. By studying blood growth patterns, doctors hope to predict who might be at risk for heart issues and monitor them closely.
In this study, patients will have blood samples taken and undergo heart imaging called cardiac MRI. This imaging helps look for signs of heart disease, also known as cardiovascular disease (CVD). Researchers will also review medical records and use past blood samples if available.
- Study Length: Patients must have completed cancer treatment at least 2 years ago.
- Eligibility: Patients aged 7 years and older who can complete an MRI without sedation.
- Tests Required: Blood samples and cardiac MRI are necessary for the study.
How understandable was the trial content above?
Hard to understand
Easy to understand